Projects funded by the NCN
Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy
2022/45/B/NZ5/01695
Keywords:
tumor oxygenation PDAC imaging reoxygenation anti-cancer therapy
Descriptors:
- NZ4_2: Physiology
- NZ5_7: Human disease treatment
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
woj.
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 23 - announced on 2022-03-28
Amount awarded: 2 863 143 PLN
Project start date (Y-m-d): 2023-01-23
Project end date (Y-m-d): 2027-01-22
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Pulse and CW EPR Oximetry Using Oxychip in Gemcitabine-Treated Murine Pancreatic TumorsAuthors:Gabriela Dziurman, Agnieszka Drzał, Aleksandra Anna Murzyn, Maciej Mikolaj Kmiec, Martyna Elas & Martyna Krzykawska-SerdaAcademic press:Molecular Imaging and Biology (rok: 2023, tom: 26, strony: 473–483), Wydawca: SpringerStatus:PublishedDOI:10.1007/s11307-023-01859-w - link to the publication